Trial intelligence / Profile preview

Metoclopramide for postoperative pain and nausea after lower abdominal surgery

IRCT20190825044609N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of metoclopramide in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Intensity of pain, Intensity of nausea and 1 more. Started Aug 2017; status: completed.

02

Drugs

metoclopramide
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20190825044609N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190825044609N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call